{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:17:41Z","timestamp":1778602661689,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["anesthesiology.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anesthesiology Clinics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.anclin.2023.03.006","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T15:20:17Z","timestamp":1681485617000},"page":"371-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blinded Pain Cocktails"],"prefix":"10.1016","volume":"41","author":[{"given":"Albert Hyukjae","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean C.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10028","key":"10.1016\/j.anclin.2023.03.006_bib1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","article-title":"Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study","volume":"387","author":"Berterame","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.anclin.2023.03.006_bib2","author":"Centers for Disease Control"},{"issue":"50\u201351","key":"10.1016\/j.anclin.2023.03.006_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.anclin.2023.03.006_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.anclin.2023.03.006_bib5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.15585\/mmwr.mm6533a3","article-title":"Increases in Fentanyl-Related Overdose Deaths - Florida and Ohio, 2013-2015","volume":"65","author":"Peterson","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anclin.2023.03.006_bib6","series-title":"Annual surveillance report of drug-related risks and outcomes","year":"2019"},{"issue":"16","key":"10.1016\/j.anclin.2023.03.006_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMp1515917","article-title":"Reducing the Risks of Relief--The CDC Opioid-Prescribing Guideline","volume":"374","author":"Frieden","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.anclin.2023.03.006_bib9","author":"Pocket"},{"issue":"12","key":"10.1016\/j.anclin.2023.03.006_bib10","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/pm\/pnab208","article-title":"Assessing Variation in State Opioid Tapering Laws: Comparing State Laws with the CDC Guideline","volume":"22","author":"Danielson","year":"2021","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/pm\/pnz038","article-title":"Reducing High-Dose Opioid Prescribing: State-Level Morphine Equivalent Daily Dose Policies, 2007-2017","volume":"21","author":"Heins","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.anclin.2023.03.006_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.09.022","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review","volume":"194","author":"Davis","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.anclin.2023.03.006_bib13","first-page":"3353","article-title":"Opioid Taper Practices Among Clinicians","volume":"14","author":"Persico","year":"2021","journal-title":"J\u00a0Pain Res"},{"issue":"10","key":"10.1016\/j.anclin.2023.03.006_bib14","first-page":"979","article-title":"Prevalence of persistent pain in the U.S. adult population: new data from the 2010 national health interview survey","volume":"15","author":"Kennedy","year":"2014","journal-title":"J\u00a0Pain"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.006_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib16","first-page":"308","article-title":"Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial","volume":"18","author":"Sullivan","year":"2017","journal-title":"J\u00a0Pain"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.006_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamainternmed.2017.8709","article-title":"Patient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Pain [published correction appears in JAMA Intern Med. 2022 Jun 1;182(6):690]","volume":"178","author":"Darnall","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5055\/jom.2019.0503","article-title":"Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization","volume":"15","author":"Kirane","year":"2019","journal-title":"J\u00a0Opioid Manag"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AJP.0b013e3182579935","article-title":"Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment","volume":"29","author":"Murphy","year":"2013","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3959(86)90071-0","article-title":"Medication management in patients with chronic non-malignant pain. A review of the use of a drug withdrawal protocol","volume":"26","author":"Buckley","year":"1986","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0304-3959(94)90166-X","article-title":"Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff controlled cocktail methods","volume":"56","author":"Ralphs","year":"1994","journal-title":"Pain"},{"issue":"19","key":"10.1016\/j.anclin.2023.03.006_bib22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/jcbfm.1989.59","article-title":"Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography","volume":"9","author":"Frost","year":"1989","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"2\u20133","key":"10.1016\/j.anclin.2023.03.006_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(02)02872-8","article-title":"Naloxone displacement at opioid receptor sites measured in\u00a0vivo in the human brain","volume":"459","author":"Melichar","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.006_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0361-9230(87)90080-3","article-title":"Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain","volume":"19","author":"Pilapil","year":"1987","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.006_bib26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0306-4522(98)00251-6","article-title":"Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in\u00a0situ hybridization study","volume":"88","author":"Peckys","year":"1999","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.006_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00426529","article-title":"Differential effects on naloxone against the diazepam-induced release of behavior in rats in three aversive situations","volume":"69","author":"Soubri\u00e9","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"issue":"16\u201317","key":"10.1016\/j.anclin.2023.03.006_bib29","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/0024-3205(82)90222-3","article-title":"Naloxone attenuates the anxiolytic action of diazepam in man","volume":"31","author":"Duka","year":"1982","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000072662","article-title":"Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice","volume":"69","author":"Singh","year":"2003","journal-title":"Pharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.anclin.2023.03.006_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2004.06.020","article-title":"Brain substrates for increased drug seeking during protracted withdrawal","volume":"47","author":"Aston-Jones","year":"2004","journal-title":"Neuropharmacology"},{"issue":"50","key":"10.1016\/j.anclin.2023.03.006_bib32","doi-asserted-by":"crossref","first-page":"11777","DOI":"10.1523\/JNEUROSCI.2329-05.2005","article-title":"Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?","volume":"25","author":"Peci\u00f1a","year":"2005","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.anclin.2023.03.006_bib34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archpsyc.63.11.1199","article-title":"Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women","volume":"63","author":"Kennedy","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.006_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11606-013-2648-1","article-title":"Prescription opioid analgesics increase the risk of depression","volume":"29","author":"Scherrer","year":"2014","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.j.pain.0000460316.58110.a0","article-title":"Change in opioid dose and change in depression in a longitudinal primary care patient cohort","volume":"156","author":"Scherrer","year":"2015","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.anclin.2023.03.006_bib37","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/pme.12201","article-title":"Opioid use 12\u00a0months following interdisciplinary pain rehabilitation with weaning","volume":"14","author":"Huffman","year":"2013","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.006_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13181-012-0269-4","article-title":"Dependence and addiction during chronic opioid therapy","volume":"8","author":"Juurlink","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.006_bib39","article-title":"The Stanford Opioid Management Model","volume":"14","author":"Prasad","year":"2014","journal-title":"Pract Pain Manag"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.006_bib40","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/j.pain.0000000000000566","article-title":"Relieving pain using dose-extending placebos: a scoping review","volume":"157","author":"Colloca","year":"2016","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.006_bib41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1523\/JNEUROSCI.19-01-00484.1999","article-title":"Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems","volume":"19","author":"Amanzio","year":"1999","journal-title":"J\u00a0Neurosci"},{"issue":"26","key":"10.1016\/j.anclin.2023.03.006_bib42","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1073\/pnas.0702413104","article-title":"Placebo effects on human mu-opioid activity during pain","volume":"104","author":"Wager","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.anclin.2023.03.006_bib43","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0269881109104848","article-title":"Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems","volume":"24","author":"Guo","year":"2010","journal-title":"J\u00a0Psychopharmacol"},{"issue":"10","key":"10.1016\/j.anclin.2023.03.006_bib44","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.pain.2012.04.026","article-title":"Placebo-induced analgesia in an operant pain model in rats","volume":"153","author":"Nolan","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.anclin.2023.03.006_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2015.08.017","article-title":"The placebo effect: From concepts to genes","volume":"307","author":"Colagiuri","year":"2015","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.006_bib46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/S1461145712000673","article-title":"The opioid placebo analgesia is mediated exclusively through \u03bc-opioid receptor in rat","volume":"16","author":"Zhang","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"44","key":"10.1016\/j.anclin.2023.03.006_bib47","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1523\/JNEUROSCI.3330-07.2007","article-title":"Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?","volume":"27","author":"Benedetti","year":"2007","journal-title":"J\u00a0Neurosci"},{"issue":"12","key":"10.1016\/j.anclin.2023.03.006_bib48","doi-asserted-by":"crossref","first-page":"e15591","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: a randomized controlled trial in irritable bowel syndrome","volume":"5","author":"Kaptchuk","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.anclin.2023.03.006_bib49","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1097\/j.pain.0000000000000700","article-title":"Open-label placebo treatment in chronic low back pain: a randomized controlled trial","volume":"157","author":"Carvalho","year":"2016","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.006_bib50","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1097\/PR9.0000000000000828","article-title":"Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control","volume":"5","author":"Morales-Quezada","year":"2020","journal-title":"Pain Rep"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.006_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2214.2007.00797.x","article-title":"Open-label use of placebos in the treatment of ADHD: a pilot study","volume":"34","author":"Sandler","year":"2008","journal-title":"Child Care Health Dev"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PSY.0b013e3181cbd38b","article-title":"Conditioned pharmacotherapeutic effects: a preliminary study","volume":"72","author":"Ader","year":"2010","journal-title":"Psychosom Med"},{"issue":"9","key":"10.1016\/j.anclin.2023.03.006_bib53","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.sleep.2015.06.015","article-title":"Durability of treatment response to zolpidem with three different maintenance regimens: a preliminary study","volume":"16","author":"Perlis","year":"2015","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.006_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000126074","article-title":"Behavioral conditioning of antihistamine effects in patients with allergic rhinitis","volume":"77","author":"Goebel","year":"2008","journal-title":"Psychother Psychosom"},{"issue":"16","key":"10.1016\/j.anclin.2023.03.006_bib55","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1073\/pnas.1720548115","article-title":"Learned immunosuppressive placebo responses in renal transplant patients","volume":"115","author":"Kirchhof","year":"2018","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.anclin.2023.03.006_bib56","first-page":"658","article-title":"Treatment strategies of operant conditioning in rehabilitation. The prevention and management of disability due to chronic pain following industrial injuries","volume":"17","author":"Kraft","year":"1975","journal-title":"J\u00a0Occup Med"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.006_bib57","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1097\/PR9.0000000000000932","article-title":"Veteran engagement in opioid tapering research: a mission to optimize pain management","volume":"6","author":"Colloca","year":"2021","journal-title":"Pain Rep"}],"container-title":["Anesthesiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227523000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227523000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:03:51Z","timestamp":1761829431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1932227523000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1932227523000198"],"URL":"https:\/\/doi.org\/10.1016\/j.anclin.2023.03.006","relation":{},"ISSN":["1932-2275"],"issn-type":[{"value":"1932-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blinded Pain Cocktails","name":"articletitle","label":"Article Title"},{"value":"Anesthesiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anclin.2023.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}